We are live on ! Find out more
AIP

Arrowpoint Investment Partners Portfolio holdings

AUM $113M
1-Year Est. Return 73.91%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+73.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$679M
AUM Growth
+$579M
Cap. Flow
+$572M
Cap. Flow %
84.27%
Top 10 Hldgs %
73.8%
Holding
153
New
75
Increased
18
Reduced
9
Closed
49

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$81.9M
2
MSFT icon
Microsoft
MSFT
+$72.7M
3
JNJ icon
Johnson & Johnson
JNJ
+$62.1M
4
HD icon
Home Depot
HD
+$57.4M
5
QCOM icon
Qualcomm
QCOM
+$53.6M

Top Sells

Rank Stock Value
1
ECHO
EchoStar
ECHO
+$3.77M
2
ALAB icon
Astera Labs
ALAB
+$3.4M
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$3.07M
4
HSAI
Hesai Group
HSAI
+$1.85M
5
FIX icon
Comfort Systems
FIX
+$1.76M

Sector Composition

Rank Sector Weight
1 Technology 42.95%
2 Healthcare 17.88%
3 Consumer Discretionary 14.6%
4 Financials 13.87%
5 Communication Services 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
51
Pfizer
PFE
$153B
$1.08M 0.16%
+43,342
New +$1.09M
TIP icon
52
iShares TIPS Bond ETF
TIP
$14.7B
$989K 0.15%
9,000
+1,500
+20% +$166K
PEN icon
53
Penumbra
PEN
$12.8B
$871K 0.13%
+2,803
New +$774K
COO icon
54
Cooper Companies
COO
$14.5B
$855K 0.13%
+10,434
New +$781K
NVS icon
55
Novartis
NVS
$297B
$855K 0.13%
+6,200
New +$812K
SE icon
56
Sea Limited
SE
$69.5B
$854K 0.13%
6,692
-1,089
-14% -$161K
CRL icon
57
Charles River Laboratories
CRL
$12.8B
$808K 0.12%
+4,053
New +$735K
TMO icon
58
Thermo Fisher Scientific
TMO
$220B
$747K 0.11%
1,290
-222
-15% -$126K
PTCT icon
59
PTC Therapeutics
PTCT
$6.12B
$702K 0.1%
9,238
+5,947
+181% +$432K
ASND icon
60
Ascendis Pharma A/S
ASND
$16.8B
$639K 0.09%
+2,997
New +$619K
AXGN icon
61
Axogen
AXGN
$2.5B
$628K 0.09%
+19,202
New +$472K
AZTA icon
62
Azenta
AZTA
$1.48B
$616K 0.09%
+18,507
New +$605K
PRAX icon
63
Praxis Precision Medicines
PRAX
$10.1B
$614K 0.09%
+2,082
New +$388K
EEM icon
64
iShares MSCI Emerging Markets ETF
EEM
$30B
$596K 0.09%
10,900
+900
+9% +$48.9K
FTRE icon
65
Fortrea Holdings
FTRE
$1.75B
$591K 0.09%
+34,253
New +$423K
BMY icon
66
Bristol-Myers Squibb
BMY
$132B
$583K 0.09%
+10,806
New +$520K
AVGO icon
67
Broadcom
AVGO
$2.04T
$574K 0.08%
+1,659
New +$593K
BIO icon
68
Bio-Rad Laboratories Class A
BIO
$9.42B
$572K 0.08%
+1,888
New +$589K
GDX icon
69
VanEck Gold Miners ETF
GDX
$27.4B
$532K 0.08%
6,200
-4,900
-44% -$387K
OMCL icon
70
Omnicell
OMCL
$1.68B
$527K 0.08%
+11,630
New +$425K
MEDP icon
71
Medpace
MEDP
$16.5B
$510K 0.08%
+908
New +$515K
BIIB icon
72
Biogen
BIIB
$30.7B
$502K 0.07%
+2,855
New +$466K
NBIX icon
73
Neurocrine Biosciences
NBIX
$16.6B
$499K 0.07%
+3,517
New +$510K
BLTE
74
Belite Bio
BLTE
$6.54B
$488K 0.07%
+3,049
New +$361K
APGE icon
75
Apogee Therapeutics
APGE
$10.2B
$477K 0.07%
+6,324
New +$398K
1 2
3
4 5

Similar funds

VCM
Veradace Capital Management Dallas, Texas $112M AUM
TBNY
Trustco Bank (New York) Albany, New York $113M AUM 34.59% 1-Year Est. Return
UOWF
University of Wisconsin Foundation Madison, Wisconsin $113M AUM 23.15% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $112M AUM
MC
Matters Capital Miami, Florida $113M AUM
ML
MSRH LLC New York $113M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM

Arrowpoint Investment Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Arrowpoint Investment Partners held 153 positions worth $679M, up 578% from $100M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Arrowpoint Investment Partners deployed $572M of net new capital in Q4 2025, opening 75 new positions and adding to 18 existing holdings. Its largest new stake was Microsoft: 145,000 shares worth $70.1M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Short-Term Corporate Bond ETF, an estimated $3.07M trimmed.

  • Arrowpoint Investment Partners's largest Q4 2025 buy was Microsoft: 145,000 shares worth $70.1M.
  • Arrowpoint Investment Partners added most to NVIDIA in Q4 2025, an estimated $81.9M increase.
  • Arrowpoint Investment Partners's biggest Q4 2025 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $3.07M.
  • Arrowpoint Investment Partners fully exited EchoStar in Q4 2025, selling an estimated $3.77M.
  • Arrowpoint Investment Partners's ten largest holdings make up 74% of its $679M portfolio in Q4 2025.
  • Arrowpoint Investment Partners opened 75 new positions and closed 49 in Q4 2025.
  • Arrowpoint Investment Partners's portfolio value rose 578% quarter-over-quarter to $679M.

Based on Arrowpoint Investment Partners's 13F filing for Q4 2025, filed 11 Feb 2026.